+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

South America Tissue Engineering Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Material Type and Application

  • PDF Icon

    Report

  • 144 Pages
  • September 2022
  • The Insight Partners
  • ID: 5668454
UP TO OFF until Mar 31st 2024
The tissue engineering market in South America is expected to grow from US$464.24 million in 2022 to US$913.73 million by 2028. It is estimated to grow at a CAGR of 10.2% from 2022 to 2028.

Tissue engineering and regenerative medicine (TERM) have been proposed and developed for more than 30 years. Although several successful attempts at tissue regeneration have been made, TERM is still in its infancy. There are many unanswered fundamental questions regarding the selection of cell sources, development of tissue-specific materials, specialized bioreactors, and the construction of complex organs. After all, most therapies or treatments aim to enhance tissue regeneration, and stem cell engineering has opened a new avenue in regenerative medicine. Tissue engineering can be applied to construct various tissues, including blood vessels, nerve tissues, skin, and bones. Several techniques involving new materials, new structures, and novel surface modifications of biomaterials are developed for stem cell engineering. Also, a deep understanding of the interactions between cells and biomaterials is needed. Advances in tissue engineering research and its methodology led to the formation of scaffolds for bioprinters and then to the decellularized organs. More research into processes is overcoming the shortcomings of previous methods. Improving knowledge in the biology of regeneration, development in microelectronics, and 3D printing technology helps overcome the hurdles. In additing, cell therapy is one of the fastest-growing segments of the regenerative medicine domain. Novartis’s Kymriah was the first cell therapy solution offered for the treatment of B-cell acute leukemia, which opened opportunities for the emerging treatment therapy. Moreover, RepliCel, a regenerative medicine provider, has a wide range of regenerative medicine products in pipeline, with three products - RCH-01, RCS-01, and RCT-01 - in the development phase. Further, Sernova is engaged in the development of regenerative medicine technologies and has a huge pipeline of the products for various conditions, including diabetes, Hemophilia A, and hyperthyroidism. Therefore, rapid advancements in the development of regenerative medicines to provide effective solutions for chronic conditions are driving the growth of the market.

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the South America tissue engineering market at a substantial CAGR during the forecast period.

South America Tissue Engineering Market Segmentation

The South America tissue engineering market is segmented on the basis of material type, application, and country.
  • Based on material type, the market is segmented into biologically derived materials, synthetic materials, and others. In 2021, the biologically derived materials segment held the largest market share. However, the synthetic materials segment is expected to register the highest CAGR during the forecast period.
  • Based on application, the market is segmented into orthopedic, musculoskeletal & spine, skin & integumentary, cardiology and vascular, neurology, cancer, gi & gynecology, urology, and others. In 2021, the orthopedic, musculoskeletal, & spine segment held the largest market share. However, the skin & integumentary segment is expected to register the highest CAGR in the market during the forecast period.
  • Based on country, the South America tissue engineering market is segmented into Brazil, Argentina, and Rest of SAM. In 2021, Brazil held the largest market share; and it is also expected to grow at the fastest CAGR during the forecast period.
Zimmer Biomet; B. Braun Melsungen AG; Stryker Corporation; AbbVie, Inc.; Integra LifeSciences Holdings Corporation; Medtronic; Baxter International Inc.; Johnson and Johnson Services, Inc.; 3M; and Cook Biotech Inc. are among the leading companies in the South America tissue engineering market.
Frequently Asked Questions about the South American Tissue Engineering Market

What is the estimated value of the South American Tissue Engineering Market?

The South American Tissue Engineering Market was estimated to be valued at $464.24 Million in 2022.

What is the growth rate of the South American Tissue Engineering Market?

The growth rate of the South American Tissue Engineering Market is 10.2%, with an estimated value of $913.73 Million by 2028.

What is the forecasted size of the South American Tissue Engineering Market?

The South American Tissue Engineering Market is estimated to be worth $913.73 Million by 2028.

Who are the key companies in the South American Tissue Engineering Market?

Key companies in the South American Tissue Engineering Market include Zimmer Biomet, B. Braun Melsungen AG, Stryker Corporation, AbbVie, Inc., Integra LifeSciences Holdings Corporation, Medtronic, Baxter International Inc., Johnson and Johnson Services, Inc., 3M and Cook Biotech Inc..

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Tissue Engineering Market - By Material Type
1.3.2 South & Central America Tissue Engineering Market - By Application
1.3.3 South & Central America Tissue Engineering Market - By Country
2. South & Central America Tissue Engineering Market Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Tissue Engineering - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinion
5. South & Central Tissue Engineering Market - Industry Dynamics
5.1 Key Drivers
5.1.1 Burgeoning Number of Road Accidents and Trauma Injuries, and Elevating Incidence of Chronic Diseases
5.1.2 Fostering Technological Advancements in the Field of 3D Tissue Engineering
5.2 Key Market Restraints
5.2.1 High Cost of Treatment Options Involving Tissue Engineering
5.3 Key Market Opportunities
5.3.1 Advancements in the Healthcare Market Across the Region
5.4 Future Trends
5.4.1 Widening Advancements in Regenerative Medicine
5.5 Impact Analysis
6. South & Central America Tissue Engineering Market Analysis
6.1 South & Central America Tissue Engineering Market Revenue Forecast and Analysis
7. South & Central America Tissue Engineering Market Analysis - By Material Type
7.1 Overview
7.2 South & Central America Tissue Engineering Market Revenue Share, by Material Type (2022 and 2028)
7.3 Synthetic Material
7.3.1 Overview
7.3.2 Synthetic Material: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Biologically Derived Materials
7.4.1 Overview
7.4.2 Biologically Derived Materials: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
8. South & Central America Tissue Engineering Market By Application
8.1 Overview
8.2 South & Central America Tissue Engineering Market, by Application, 2022 and 2028 (%)
8.3 Orthopedic, Musculoskeletal & Spine
8.3.1 Overview
8.3.2 Orthopedic, Musculoskeletal & Spine: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Neurology
8.4.1 Overview
8.4.2 Neurology: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Cardiology & Vascular
8.5.1 Overview
8.5.2 Cardiology & Vascular: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Skin & Integumentary
8.6.1 Overview
8.6.2 Skin & Integumentary: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
8.7 Cancer
8.7.1 Overview
8.7.2 Cancer: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
8.8 GI & Gynaecology
8.8.1 Overview
8.8.2 GI & Gynaecology: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
8.9 Urology
8.9.1 Overview
8.9.2 Urology: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
8.10 Others
8.10.1 Overview
8.10.2 Others: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9. South & Central America Tissue Engineering Market Country Analysis
9.1 Overview
9.1.1 South & Central America: Tissue Engineering Market, by Country, 2022 & 2028 (%)
9.1.1.1 Brazil: - Revenue and Forecast to 2028 (US$ Million)
9.1.1.1.1 Brazil: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.1.2 Brazil Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.1.1.1.3 Brazil Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.1.1.2 Argentina: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.2.1 Argentina: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.2.2 Argentina Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.1.1.2.3 Argentina Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.1.1.3 Rest of South & Central America: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.3.1 Rest of South & Central America: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.3.2 Rest of South & Central America Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.1.1.3.3 Rest of South & Central America Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10. South & Central America Tissue Engineering Market Industry Landscape
10.1 Organic Developments
10.1.1 Overview
10.2 Inorganic Developments
10.2.1 Overview
11. Company Profiles
11.1 Zimmer Biomet
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 B. Braun Melsungen AG
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Stryker Corporation
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 AbbVie, Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Integra LifeSciences Holdings Corporation
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Medtronic
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Baxter International Inc.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Johnson and Johnson Services, Inc.
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 3M
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Cook Biotech Inc.
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About the Publisher
12.2 Glossary of Terms

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Zimmer Biomet
  • B. Braun Melsungen AG
  • Stryker Corporation
  • AbbVie, Inc.
  • Integra LifeSciences Holdings Corporation
  • Medtronic
  • Baxter International Inc.
  • Johnson and Johnson Services, Inc.
  • 3M
  • Cook Biotech Inc.